Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

7 results
Display

Understanding Cancer Pain and Controlling Pain: Focusing on Patients With Metastatic Urologic Cancer

Jo J, Han S, Huh JS

Urinary tumors include cancers that commonly occur throughout the population, such as bladder cancer, kidney cancer, ureter cancer, and prostate cancer. The incidence of urological tumors in Korea is increasing....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expert Group Consensus Opinion on Prostate Cancer Diagnosis and Management in India: Part 2 of 2

Ghose A, Khochikar M, Sabnis R, Parmar NM, Purkait I

With limited/no guidelines on prostate cancer (PCa) diagnosis and management currently in India, this consensus statement has been developed to evaluate Indian literature and current clinical practices to assist healthcare...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Development of Antibody-Drug Conjugates for Urothelial Carcinoma Treatment

Choi DS, Kang SJ, Chang IH, Choi YW

Urothelial cancer is the seventh most common cancer among men worldwide. Bacille de Calmette-Guérin is a type of anticancer immunotherapy that has been used to treat targeted bladder cancer, but...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Coffee Consumption and Risk of Prostate Cancer in Local, Advanced, and Fatal Grades: A Meta-Epidemiological Study of Prospective Cohort Studies

Bae JM

There were conflict reports among the previous systematic reviews conducted to evaluate the association between coffee consumption and risk of prostate cancer. This meta-epidemiological study aimed to evaluate the reasons...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Serum Testosterone Level as Possible Predictive Marker for Prognosis in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Enzalutamide

An DH, Kim H, Lee D, Jeong IG, You D, Hong JH, Kim CS, Ahn H

Purpose: This study aimed to evaluate the impact of serum testosterone level before enzalutamide treatment in metastatic castration-resistant prostate cancer (mCRPC) for antitumor outcomes. Materials and Methods: Single-center, retrospective study including...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effects of Recombinant Bacillus Calmette-Guérin Resistant to Antimicrobial Peptides on Orthotopic Bladder Cancer Mouse Model

Hong SJ, Hwang GY, Kang SJ, Choi SY, Chi BH, Chang IH

Purpose: Although Mycobacterium bovis Bacillus Calmette-Guérin (BCG) is the most widely used bladder cancer immunotherapy, innate immune responses involving antimicrobial peptides (AMPs) cause BCG failure. Here, we developed genetically modified...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Real-World Experience of Single-Center, Retrospective Study of the Prognostic Effect of Secondary Hormone Agent on Survival in Patients With Hormone-Refractory Metastatic Prostate Cancer

Kim SH, Lee DE, Seo HK, Chung J, Joung JY

Purpose: This study aimed to analyze the overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with either combination or only secondary hormone therapy (2ndHTx) or docetaxel...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr